Allergies are a common problem faced by millions of people. While they can occur any time of the year, most people experience them during the spring due to pollen. The following reports examine the global allergy medicine market and where it's headed.
Statistics show that 10% to 30% of the general population suffers from seasonal allergies. Also known as allergic rhinitis or hay fever, it's characterized by symptoms such as sneezing, runny nose, itchy eyes, red eyes and malaise from exposure to pollen.
These symptoms can last anywhere from a few hours to several days. But the good news is that there are drugs used to treat allergies, allowing sufferers to get back to their normal daily routine.
Some people assume that allergies are caused by a virus or bacteria, but this isn't necessarily true. They are actually caused by our bodies' immune system.
If you have an overactive immune system, it may identify grass pollen or other substances as being harmful even when those substances are completely safe. Once identified as harmful, the immune system will attack it with white blood cells, causing local cells to release histamines.
As histamines are released, inflammation occurs, resulting in the symptoms of an allergy attack.
There are dozens of drugs and medicines, however, that can treat and prevent allergies. Antihistamines, for instance, are used to suppress to the body's histamine response.
When taken, your body will release fewer histamines, thereby weakening your allergy attacks. Antihistamines are just one of many types of drugs used to treat allergies.
There are also nasal sprays, immune-boosting medicines and other drugs.
The Global Grass Pollen Allergy Drug M… Forecast to 2025 report by The Market Reports is a comprehensive study of the global grass pollen allergy drug market. Featuring 113 pages, it provides a detailed analysis of the market and where it's headed.
This report segments the global grass pollen allergy drug market by several criteria. On the basis of product type, the market is segmented into BM-32, Pollinez Quattro Grass and others.
On the basis of end-user application, the market is segmented into home use, hospital use and research center use.
The Global Allergy Medicine Sales Market 2018 report by The Market Reports is a second professional study of the global allergy medicine market. However, this report covers all allergy medicines, whereas the first report focuses specifically on medicines used to treat pollen allergies.
Grass pollen is just one type of allergy. Some people are allergic to mold, for example, whereas others are allergic to nickel.
This report explores medicine used to treat all different types of allergies.
Some of the key vendors profiled in this report include Sanofi, Johnson & Johnson, Bayer, Matrixx Initiatives, AstraZeneca, Gsk, Pfizer, Chattem and others.
For more information: